Sort
82,697 grants matching “vaccine development”
Task B05: Refinement of a Pig-Tail Macaque model of Gonococcal Infection
$994,264Hanne Andersen · Bioqual, Inc. · N01 · FY2020 · AI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility
$994,203Masahiro Yamashita · Columbia University Health Sciences · R61 · FY2025 · AI
A multivalent O-antigen bioconjugate vaccine for the prevention of Klebsiella pneumoniae infections
$994,178Christian Harding · Vaxnewmo, Llc · R42 · FY2024 · AI
Project 1: PREVENT Program Critical Path Project
$994,174Daniel Tuse · University Of Louisville · U19 · FY2014 · AI
DEVELOPMENT OF A PRIMATE GENOMIC RESOURCE
$994,165Michael G Katze · University Of Washington · R24 · FY2011 · RR
DEVELOPMENT OF A PRIMATE GENOMIC RESOURCE
$994,165Michael G Katze · University Of Washington · R24 · FY2012 · OD
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
$994,162Charles T Roberts · Oregon Health & Science University · R01 · FY2023 · DK
Development of a Yellow Fever Vaccine for Vulnerable Population
$994,154Ian James Amanna · Najit Technologies, Inc. · R44 · FY2013 · AI
Recombinant Subunit Vaccine For Tick-Borne Encephalitis
$994,040Beth-Ann Coller · Hawaii Biotech, Inc. · R44 · FY2009 · AI
New Animal Models for Tuberculosis
$993,992Michelle Linehan · Johns Hopkins University · N01 · FY2013 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$993,983Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2016 · AI
In vivo testing of novel HIV Env vaccine platforms to advance preclinical HIV vaccine development
$993,962Gavin Morrow · International Aids Vaccine Initiative · P01 · FY2020 · AI
A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome
$993,938Joana M Murad · Celdara Medical, Llc · R42 · FY2024 · AI
Core B
$993,882Galit Alter · Beth Israel Deaconess Medical Center · U19 · FY2022 · AI
mRNA-based chimeric membrane protein vaccination strategies directed at the MPER
$993,881Mikyung Kim · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Novel strategy to block AAV neutralizing antibody activity
$993,865Charles H Askew · Nabgen, Inc. · R42 · FY2025 · TR
Conformational Stabilization of the HIV-1 Env Trimer
$993,663Christopher Marshall · Avatar Medical, Llc · R44 · FY2014 · AI
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$993,629Benjamin Michael Looney · Inspira Therapeutics, Inc. · R44 · FY2021 · DK
Midwest Developmental Center for AIDS Research (D-CFAR)
$993,578Elvin H. Geng · Washington University · P30 · FY2025 · AI
Attenuated Sporozoite Malaria Vaccine
$993,547Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2009 · AI
PEDIATRIC AIDS CLINICAL TRIAL UNIT
$993,528Univ Of Massachusetts Med Sch Worcester · U01 · FY2003 · AI
Recombinant Subunit Vaccine For Tick-Borne Encephalitis
$993,477David E. Clements · Hawaii Biotech, Inc. · R44 · FY2011 · AI
Attenuated Sporozoite Malaria Vaccine
$993,465Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
Cryopreservation and delivery of sporozoite vaccine
$993,429Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
The mucosal immune system: effects of aging and chronic antigenic stimulation
$993,364Rita Brickman Effros · University Of California Los Angeles · R01 · FY2012 · AG